Sonoelastographic lesion stiffness: preoperative predictor of the presence of an invasive focus in nonpalpable DCIS diagnosed at US-guided needle biopsy
Abstract:Sonoelastographic lesion stiffness is an independent preoperative predictor of invasion in some patients with nonpalpable DCIS at US-guided needle biopsy.
“…The previous study reported that the mean elasticity score of intraductal papillomas was higher than that of benign proliferative lesions (2.9±1.0 vs. 1.7±0.9, respectively) (P<0.01) [2]. However, contrary to their results showing no difference in elasticity scores between DCIS and IDC, we found that the mean elasticity score of IDC was higher than that of DCIS (3.26±0.09 vs. 2.54±0.11, respectively) (P<0.001), which is similar to the results of another study [17].…”
• Sonoelastography has higher specificity than B-mode ultrasound in distinguishing benign from malignant masses. • Sonoelastography could potentially help reduce the number of biopsies with benign results. • Lesion stiffness on sonoelastography correlated with the malignant potential of the lesion.
“…The previous study reported that the mean elasticity score of intraductal papillomas was higher than that of benign proliferative lesions (2.9±1.0 vs. 1.7±0.9, respectively) (P<0.01) [2]. However, contrary to their results showing no difference in elasticity scores between DCIS and IDC, we found that the mean elasticity score of IDC was higher than that of DCIS (3.26±0.09 vs. 2.54±0.11, respectively) (P<0.001), which is similar to the results of another study [17].…”
• Sonoelastography has higher specificity than B-mode ultrasound in distinguishing benign from malignant masses. • Sonoelastography could potentially help reduce the number of biopsies with benign results. • Lesion stiffness on sonoelastography correlated with the malignant potential of the lesion.
“…Because invasive cancers tend to be stiffer than DCIS lesions, homogeneous stiffness on strain elastography predicted an increased likelihood of an upgrade to invasive carcinoma at excision after a core biopsy showing DCIS in one series [25]. We confirmed that DCIS is softer, on average, than invasive breast cancer, with a median Emax of 126 kPa for DCIS versus 180 kPa for invasive cancers (p = 0.002) in our series.…”
Despite overlap in Emax values, maximum stiffness measured by SWE is a highly effective predictor of the histopathologic severity of sonographically depicted breast masses.
“…This result can be explained by the fact that DCIS tends to show less suspicious features than invasive cancers on B-mode ultrasonography [22], tending to be classified as BI-RADS category 3. Furthermore, as DCIS is softer than invasive cancers [16], it is more difficult to distinguish DCIS from benign lesions than to distinguish invasive cancers from benign lesions on US elastography. In a previous study using the same elasticity score as our study, although the mean elasticity score of DCIS was higher than that of benign disease (2.54±0.11 vs. 1.78±0.81; P<0.001), the mean elasticity score of DCIS was lower than that of invasive ductal carcinomas (2.54±0.11 vs. 3.26±0.09; P<0.001) [14].…”
Purpose:To evaluate the negative predictive value (NPV) of ultrasound (US) elastography for non-palpable Breast Imaging Reporting and Data System (BI-RADS) category 3 lesions on ultrasonography and to determine whether US elastography is helpful in reducing the number of BI-RADS category 3 lesions on ultrasonography.Methods:Two hundred seventy-six consecutive, non-palpable BI-RADS category 3 lesions in 256 women who underwent US elastography and US-guided core biopsy, and who had at least 12 months of follow-up data, comprised our study group. The BI-RADS final assessment category and elasticity score were prospectively and independently classified. The rate of malignancy and NPV according to the elasticity score were analysed. We also investigated whether there was a subset of BI-RADS category 3 lesions that were of benign histology but negative on elastography.Results:Of the 276 non-palpable BI-RADS category 3 lesions, three lesions (1.0%) were finally confirmed as ductal carcinomas in situ. No cancers were found in the remaining 273 lesions with benign biopsy histology at a mean follow-up of 39.4 months (range, 12 to 72 months). The NPV of a negative elasticity score (elasticity score of 1) was 99.3% (165 of 166). If BI-RADS category 3 lesions showing a negative elasticity score were downgraded to BI-RADS category 2, 60.4% (165 of 273) of them with benign histology could have been safely followed without biopsy with an increased malignancy rate from 1% (3 of 276) to 1.8% (2 of 110), which is not significantly higher (P=0.626).Conclusion:US elastography has the potential to reduce the number of BI-RADS category 3 lesions on ultrasonography.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.